To identify embryotoxic compounds, scientists developed an hiPSC-based biomarker assay based on the differentiation of hiPSCs into functional cardiomyocytes and hepatocytes.
[Birth Defects Research]
6445212
BBBBBBBB
items
1
apa
0
default
asc
1
172878
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
